Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Serum uric acid levels in patients with Parkinson's disease: Their relationship to treatment and disease duration
Clinical Neurology and Neurosurgery, 10/07/09
Andreadou E et al. – The results suggest that there may be increased consumption of UA as a scavenger in PD, possibly heightened by dopaminergic drug treatment. Given the antioxidant properties of UA, manipulation of its concentrations should be investigated for potential therapeutic strategies of the disease.
Related Articles
Widely Used Cholesterol-lowering Drug May Prevent Progression Of Parkinsons Disease
ScienceDaily, 11/10/09
Relevance Score: 70%
Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia
Brain, 10/30/09
Relevance Score: 70%
Effects of optimism/pessimism and locus of control on disability and quality of life in Parkinson's disease
Parkinsonism & Related Disorders, 10/29/09
Relevance Score: 69%
Sleep disturbances in Malaysian patients with Parkinson's disease using polysomnography and PDSS
Parkinsonism & Related Disorders, 10/29/09
Relevance Score: 69%
Condition Raises Parkinsons Risk 5-Fold
Ivanhoe, 10/27/09
Relevance Score: 69%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Re-evaluation of the dysequilibrium syndrome
Acta Neurologica Scandinavica, 03/21/10
O6-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma
International Journal of Clinical Oncology, 03/21/10
Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease
Journal of Neurology, Neurosurgery, and Psychiatry , 03/19/10
Today in Movement Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and tolerability of rasagiline in daily clinical use – a post-marketing observational study in patients with Parkinsons disease
European Journal of Neurology, 03/21/10
Familial associations of Alzheimer disease and essential tremor with Parkinson disease
European Journal of Neurology, 03/21/10
Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease
Journal of Neurology, Neurosurgery, and Psychiatry , 03/19/10
Article Search
Sponsor
Sponsor


See Latest Articles


